This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dussault, I. Articles by Forman, B. M. Search for Related Content PubMed PubMed Citation Articles by Dussault, I. Articles by Forman, B. M.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, August 2002, p. 5270-5280, Vol. 22, No. 15
0270-7306/02/$04.00+0     DOI: 10.1128/MCB.22.15.5270-5280.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

A Structural Model of the Constitutive Androstane Receptor Defines Novel Interactions That Mediate Ligand-Independent Activity

Division of Molecular Medicine,,¹ Division of Biology,,² Department of Biomedical Informatics,³ Gonda Diabetes & Genetic Research Center, Beckman Research Institute of the City of Hope National Medical Center, Duarte, California 91010⁴

Received 1 February 2002/ Returned for modification 7 March 2002/ Accepted 25 April 2002

Unlike classical nuclear receptors that require ligand for transcriptional activity, the constitutive androstane receptor (CAR) is active in the absence of ligand. To determine the molecular contacts that underlie this constitutive activity, we created a three-dimensional model of CAR and verified critical structural features by mutational analysis. We found that the same motifs that facilitate ligand-dependent activity in classical receptors also mediated constitutive activity in CAR. This raises a critical question: how are these motifs maintained in an active conformation in unliganded CAR? The model identified several novel interactions that account for this activity. First, CAR possesses a short loop between helix 11 and the transactivation domain (helix 12), as well as a short carboxy-terminal helix. Together, these features favor ligand-independent docking of the transactivation domain in a position that is characteristic of ligand-activated receptors. Second, this active conformation is further stabilized by a charge-charge interaction that anchors the carboxy-terminal activation domain to helix 4. Mutational analysis of these interactions provides direct experimental support for this model. We also show that ligand-mediated repression of constitutive activity reflects both a displacement of coactivator and a recruitment of corepressor. Our data demonstrate that CAR utilizes the same conserved structural motifs and coregulator proteins as originally defined for classical nuclear receptors. Despite these remarkable similarities, our model demonstrates how a few critical changes in CAR can dramatically reverse the transcriptional activity of this protein.

This article has been cited by other articles:

• Michalik, L., Zoete, V., Krey, G., Grosdidier, A., Gelman, L., Chodanowski, P., Feige, J. N., Desvergne, B., Wahli, W., Michielin, O. (2007). Combined Simulation and Mutagenesis Analyses Reveal the Involvement of Key Residues for Peroxisome Proliferator-activated Receptor{alpha} Helix 12 Dynamic Behavior. J. Biol. Chem. 282: 9666-9677 [Abstract] [Full Text]  
• Auerbach, S. S., DeKeyser, J. G., Stoner, M. A., Omiecinski, C. J. (2007). CAR2 Displays Unique Ligand Binding and RXR{alpha} Heterodimerization Characteristics. Drug Metab. Dispos. 35: 428-439 [Abstract] [Full Text]  
• Winnay, J. N., Hammer, G. D. (2006). Adrenocorticotropic Hormone-Mediated Signaling Cascades Coordinate a Cyclic Pattern of Steroidogenic Factor 1-Dependent Transcriptional Activation. Mol. Endocrinol. 20: 147-166 [Abstract] [Full Text]  
• Auerbach, S. S., Stoner, M. A., Su, S., Omiecinski, C. J. (2005). Retinoid X Receptor-{alpha}-Dependent Transactivation by a Naturally Occurring Structural Variant of Human Constitutive Androstane Receptor (NR1I3). Mol. Pharmacol. 68: 1239-1253 [Abstract] [Full Text]  
• Lempiainen, H., Molnar, F., Macias Gonzalez, M., Perakyla, M., Carlberg, C. (2005). Antagonist- and Inverse Agonist-Driven Interactions of the Vitamin D Receptor and the Constitutive Androstane Receptor with Corepressor Protein. Mol. Endocrinol. 19: 2258-2272 [Abstract] [Full Text]  
• Molnar, F., Matilainen, M., Carlberg, C. (2005). Structural Determinants of the Agonist-independent Association of Human Peroxisome Proliferator-activated Receptors with Coactivators. J. Biol. Chem. 280: 26543-26556 [Abstract] [Full Text]  
• Jyrkkarinne, J., Windshugel, B., Makinen, J., Ylisirnio, M., Perakyla, M., Poso, A., Sippl, W., Honkakoski, P. (2005). Amino Acids Important for Ligand Specificity of the Human Constitutive Androstane Receptor. J. Biol. Chem. 280: 5960-5971 [Abstract] [Full Text]  
• Frank, C., Molnar, F., Matilainen, M., Lempiainen, H., Carlberg, C. (2004). Agonist-dependent and Agonist-independent Transactivations of the Human Constitutive Androstane Receptor Are Modulated by Specific Amino Acid Pairs. J. Biol. Chem. 279: 33558-33566 [Abstract] [Full Text]  
• Swales, K., Negishi, M. (2004). CAR, Driving into the Future. Mol. Endocrinol. 18: 1589-1598 [Abstract] [Full Text]  
• Jinno, H., Tanaka-Kagawa, T., Hanioka, N., Ishida, S., Saeki, M., Soyama, A., Itoda, M., Nishimura, T., Saito, Y., Ozawa, S., Ando, M., Sawada, J.-i. (2004). Identification of Novel Alternative Splice Variants of Human Constitutive Androstane Receptor and Characterization of Their Expression in the Liver. Mol. Pharmacol. 65: 496-502 [Abstract] [Full Text]  
• Adachi, R., Shulman, A. I., Yamamoto, K., Shimomura, I., Yamada, S., Mangelsdorf, D. J., Makishima, M. (2004). Structural Determinants for Vitamin D Receptor Response to Endocrine and Xenobiotic Signals. Mol. Endocrinol. 18: 43-52 [Abstract] [Full Text]  
• Handschin, C., Meyer, U. A. (2003). Induction of Drug Metabolism: The Role of Nuclear Receptors. Pharmacol. Rev. 55: 649-673 [Abstract] [Full Text]  
• Auerbach, S. S., Ramsden, R., Stoner, M. A., Verlinde, C., Hassett, C., Omiecinski, C. J. (2003). Alternatively spliced isoforms of the human constitutive androstane receptor. Nucleic Acids Res 31: 3194-3207 [Abstract] [Full Text]  
• Farboud, B., Hauksdottir, H., Wu, Y., Privalsky, M. L. (2003). Isotype-Restricted Corepressor Recruitment: a Constitutively Closed Helix 12 Conformation in Retinoic Acid Receptors {beta} and {gamma} Interferes with Corepressor Recruitment and Prevents Transcriptional Repression. Mol. Cell. Biol. 23: 2844-2858 [Abstract] [Full Text]  
• Shiraki, T., Sakai, N., Kanaya, E., Jingami, H. (2003). Activation of Orphan Nuclear Constitutive Androstane Receptor Requires Subnuclear Targeting by Peroxisome Proliferator-activated Receptor gamma Coactivator-1alpha . A POSSIBLE LINK BETWEEN XENOBIOTIC RESPONSE AND NUTRITIONAL STATE. J. Biol. Chem. 278: 11344-11350 [Abstract] [Full Text]  
• Hauksdottir, H., Farboud, B., Privalsky, M. L. (2003). Retinoic Acid Receptors {beta} and {gamma} Do Not Repress, But Instead Activate Target Gene Transcription in Both the Absence and Presence of Hormone Ligand. Mol. Endocrinol. 17: 373-385 [Abstract] [Full Text]  
• Andersin, T., Vaisanen, S., Carlberg, C. (2003). The Critical Role of Carboxy-Terminal Amino Acids in Ligand-Dependent and -Independent Transactivation of the Constitutive Androstane Receptor. Mol. Endocrinol. 17: 234-246 [Abstract] [Full Text]